Molecular Analysis of the Candida albicans Homolog of Saccharomyces cerevisiae MNN9 , Required for Glycosylation of Cell Wall Mannoproteins
- 15 December 1999
- journal article
- research article
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 181 (24) , 7439-7448
Abstract
The fungal cell wall has generated interest as a potential target for developing antifungal drugs, and the genes encoding glucan and chitin in fungal pathogens have been studied to this end. Mannoproteins, the third major component of the cell wall, contain mannose in either O- or N-glycosidic linkages. Here we describe the molecular analysis of the Candida albicans homolog ofSaccharomyces cerevisiae MNN9, a gene required for the synthesis of N-linked outer-chain mannan in yeast, and the phenotypes associated with its disruption. CaMNN9 has significant homology with S. cerevisiae MNN9, including a putative N-terminal transmembrane domain, and represents a member of a similar gene family in Candida. CaMNN9 resides on chromosome 3 and is expressed at similar levels in both yeast and hyphal cells. Disruption of both copies of CaMNN9 leads to phenotypic effects characteristic of cell wall defects including poor growth in liquid media and on solid media, formation of aggregates in liquid culture, osmotic sensitivity, aberrant hyphal formation, and increased sensitivity to lysis after treatment with β-1,3-glucanase. Like all members of the S. cerevisiae MNN9 gene family theCamnn9Δ strain is resistant to sodium orthovanadate and sensitive to hygromycin B. Analysis of cell wall-associated carbohydrates showed the Camnn9Δ strain to contain half the amount of mannan present in cell walls derived from the wild-type parent strain. Reverse transcription-PCR and Northern analysis of the expression of MNN9 gene family members CaVAN1and CaANP1 in the Camnn9Δ strain showed that transcription of those genes is not affected in the absence ofCaMNN9 transcription. Our results suggest that, while the role MNN9 plays in glycosylation in bothCandida and Saccharomyces is conserved, loss ofMNN9 function in C. albicans leads to phenotypes that are inconsistent with the pathogenicity of the organism and thus identify CaMnn9p as a potential drug target.Keywords
This publication has 60 references indexed in Scilit:
- Identification of the MNN2 and MNN5Mannosyltransferases Required for Forming and Extending the Mannose Branches of the Outer Chain Mannans of Saccharomyces cerevisiaeJournal of Biological Chemistry, 1998
- Phenotype in Candida albicans of a disruption of the BGL2 gene encoding a 1,3-β-glucosyltransferaseMicrobiology, 1997
- Localization of an alpha 1,2 galactosyltransferase activity to the Golgi apparatus of Schizosaccharomyces pombe.Molecular Biology of the Cell, 1994
- The Recognition of Host Cells by the Pathogenic Yeast, Candida albicans.Nippon Ishinkin Gakkai Zasshi, 1994
- PUTATIVE VIRULENCE FACTORS OF CANDIDA ALBICANSAnnual Review of Microbiology, 1991
- [36] Isolation, characterization, and properties of Saccharomyces cerevisiae mnn mutants with nonconditional protein glycosylation defects1990
- A Method for Gene Disruption That Allows Repeated Use of URA3 Selection in the Construction of Multiply Disrupted Yeast StrainsGenetics, 1987
- Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutationsMolecular Genetics and Genomics, 1984
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1983
- An extensive deletion causing overproduction of yeast iso-2-cytochrome cCell, 1981